Our lab seeks to uncover how molecular signaling pathways, including calcium dynamics and endocannabinoid–opioid interactions, shape the brain circuits involved in substance use and mood disorders. By combining advanced genetic, molecular, and circuit-level approaches, we aim to reveal the mechanisms that contribute to addiction vulnerability and neuropsychiatric disease.